Rexahn Pharmaceuticals is clinical stage biopharmaceutical company developing therapies to improve patient outcomes in cancers. Co.'s pipeline features two oncology product candidates in clinical development and additional compounds in pre-clinical development. Co.'s drug candidates are: RX-3117, which is an investigational oral small molecule nucleoside compound that provides the potential for a targeted anti-cancer therapy; RX-5902, which is a small molecule modulator that modulates the pathway via inhibition of phosphorylated p68 which hinders the transport of beta-catenin into the nucleus and reduces the activation of cancer genes; and RX-0301, which is a potential potent inhibitor. We show 10 historical shares outstanding datapoints in our REXN shares outstanding history coverage, used to compute REXN market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing REXN market cap history over the course of time is important for investors
interested in comparing REXN's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of REXN versus a peer is one thing; comparing
REXN market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like REXN can fluctuate over the course of history.
With this page we aim to empower investors researching REXN by allowing them to research the REXN market cap history. |
Free REXN Email Alerts:
Video: The Importance of Market Cap
